OCBCO
SGMO

Oversea-Chinese Banking Corp (OCBC)’s SANGAMO THERAPEUTICS INC SGMO Stock Holding History

Oversea-Chinese Banking Corp (OCBC)’s Portfolio SGMO Stock Details SGMO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-17,259
Closed -$54K – 381
2022
Q4 		$54K Buy
+17,259
New +$67K ﹤0.01% 340

Other funds holding SGMO

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
RCMU
Rokos Capital Management (UK) London, United Kingdom $13.2B AUM 85.71% 1-Year Est. Return
CS
Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Oversea-Chinese Banking Corp (OCBC)'s SGMO Position: Q1 2023 in Review

Oversea-Chinese Banking Corp (OCBC) sold out of SANGAMO THERAPEUTICS INC (SGMO) in Q1 2023, closing a stake of 17,259 shares — an estimated $54K sold.

Oversea-Chinese Banking Corp (OCBC) first reported a position in SGMO in Q4 2022 and held it in 1 quarter. The position peaked at $54K in Q4 2022. 179 funds tracked by Wall St. Rank hold SGMO as of Q1 2023.

  • Oversea-Chinese Banking Corp (OCBC) reported no remaining SANGAMO THERAPEUTICS INC position as of Q1 2023 after selling out during the quarter.
  • Oversea-Chinese Banking Corp (OCBC) sold 17,259 SANGAMO THERAPEUTICS INC shares in Q1 2023, an estimated $54K.
  • Oversea-Chinese Banking Corp (OCBC) first reported a position in SANGAMO THERAPEUTICS INC in Q4 2022 and held it in 1 quarter.
  • Oversea-Chinese Banking Corp (OCBC)'s SANGAMO THERAPEUTICS INC position peaked at $54K in Q4 2022.
  • 179 funds tracked by Wall St. Rank held SANGAMO THERAPEUTICS INC as of Q1 2023.

Based on Oversea-Chinese Banking Corp (OCBC)'s 13F filing for Q1 2023, filed 4 May 2023.